14-3-3ε is important for neuronal migration by binding to NUDEL: A molecular explanation for Miller-Dieker syndrome

Nature Genetics

Volumn 34, Issue 3, 2003, Pages 274-285

  Toyo Oka, Kazuhito ^a   Shionoya, Aki ^b   Gambello, Michael J ^a,e   Cardoso, Carlos ^c,f   Leventer, Richard ^c,g   Ward, Heather L ^c   Ayala, Ramses ^d   Tsai, Li Huei ^d   Dobyns, William ^c   Ledbetter, David ^c   Hirotsune, Shinji ^b   Wynshaw Boris, Anthony ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF CHICAGO   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f TIMONE HOSPITAL   (France)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

14 3 3EPSILON PROTEIN; CYCLIN DEPENDENT KINASE 5; DYNEIN ADENOSINE TRIPHOSPHATASE; PROTEIN; PROTEIN NUDEL; PROTEIN P35; UBIQUITOUS PHOSPHOSERINE THREONINE BINDING PROTEIN; UNCLASSIFIED DRUG; 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CDK5 PROTEIN, HUMAN; CDK5 PROTEIN, MOUSE; CELL CYCLE PROTEIN; COATOMER PROTEIN; CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR; GREEN FLUORESCENT PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; PAFAH1B1 PROTEIN, HUMAN; PAFAH1B1 PROTEIN, MOUSE; PHOSPHOPROTEIN PHOSPHATASE; PHOTOPROTEIN; PROTEIN 14 3 3; PROTEIN KINASE C; TYROSINE 3 MONOOXYGENASE; YWHAE PROTEIN, HUMAN;

AGYRIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL MIGRATION; CHROMOSOME 17P; CHROMOSOME DELETION; CONTROLLED STUDY; DISEASE SEVERITY; GENE; GENE MUTATION; HETEROZYGOSITY; LIS1 GENE; MILLER DIEKER SYNDROME; MOLECULAR MODEL; MOUSE; NERVE CELL DIFFERENTIATION; NEURONAL MIGRATION; NONHUMAN; PAFAH1B1 GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; YWHAE GENE; ANIMAL; BRAIN; BRAIN DISEASE; C57BL MOUSE; CELL CULTURE; CELL MOTION; CONGENITAL MALFORMATION; CYTOLOGY; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MULTIPLE MALFORMATION SYNDROME; NERVE CELL; PATHOLOGY; SYNDROME;

ACRONICTA LEPORINA; ANIMALIA;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 14-3-3 PROTEINS; ABNORMALITIES, MULTIPLE; ANIMALS; BRAIN; BRAIN DISEASES; CELL CYCLE PROTEINS; CELL MOVEMENT; CELLS, CULTURED; COATOMER PROTEIN; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; DYNEIN ATPASE; ENZYME INHIBITORS; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LUMINESCENT PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE C; SYNDROME; TYROSINE 3-MONOOXYGENASE;

EID: 0038757833     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1169     Document Type: Article

References (50)

1. Dobyns, W.B., Reiner, O., Carrozzo, R. & Ledbetter, D.H. Lissencephaly. A human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. J. Am. Med. Assoc. 270, 2838-2842 (1993).
2. Dobyns, W.B., Curry, C.J., Hoyme, H.E., Turlington, L. & Ledbetter, D.H. Clinical and molecular diagnosis of Miller-Dieker syndrome. Am. J. Hum. Genet. 48, 584-594 (1991).
3. Dobyns, W.B., Elias, E.R., Newlin, A.C., Pagon, R.A. & Ledbetter, D.H. Causal heterogeneity in isolated lissencephaly. Neurology42, 1375-1388 (1992).
4. Ledbetter, S.A., Kuwano, A., Dobyns, W.B. & Ledbetter, D.H. Microdeletions of chromosome 17p13 as a cause of isolated lissencephaly. Am. J. Hum. Genet. 50, 182-189 (1992).
5. Chong, S.S. et al. A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. Hum. Mol. Genet. 6, 147-155 (1997).
6. Reiner, O. et al. Isolation of a Miller-Dieker lissencephaly gene containing G protein β-subunit-like repeats. Nature 364, 717-721 (1993).
7. Lo Nigro, C. et al. Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum. Mol. Genet. 6, 157-164 (1997).
8. Hirotsune, S. et al. Graded reduction of Pafahlbl (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat. Genet. 19, 333-339 (1998).
9. Gambello, M.J. et al. Multiple dose dependent effects of Lis1 on cerebral cortical development. J. Neurosci. 23, 1719-1729 (2003).
10. Cahana, A. et al. Targeted mutagenesis of Lis1 disrupts cortical development and LIS1 homodimerization. Proc. Natl. Acad. Sci. USA 98, 6429-6434 (2001).
11. Wynshaw-Boris, A. & Gambello, M.J. LIS1 and dynein motor function in neuronal migration and development. Genes Dev. 15, 639-651 (2001).
12. Gupta, A., Tsai, L.-H. & Wynshaw-Boris, A. Life is a journey: a genetic look at neocortical development. Nat. Rev. Genet. 3, 342-355 (2002).
13. Morris, R.N. Nuclear migration: from fungi to the mammalian brain. J. Cell Biol. 148, 1097-1101 (2000).
14. Sasaki, S. et al. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron 28, 681-696 (2000).
15. Niethammer, M. et al. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28, 697-711 (2000).
16. Oshima, T. etal. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA 93, 11173-11178 (1996).
17. Chae, T. et al. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18, 29-42 (1997).
18. Pilz, D.T. et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum. Mol. Genet. 7, 2029-2037 (1998).
19. Cardoso, C. et al. The location and type of mutation predict malformation severity in isolated lissencephaly caused by abnormalities within the LIS1 gene. Hum. Mol. Genet. 9, 3019-3028 (2000).
20. Fu, H., Subramanian, R.R. & Masters, S.C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40, 617-647 (2000).
21. Muslin, A.J. & Xing, H. 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell. Signal. 12, 703-709 (2000).
22. Tzivion, G. & Avruch, J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 277, 3061-3064 (2002).
23. Muslin, A.J., Tanner, J.W., Allen, P.M. & Shaw, A.S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84, 889-897 (1996).
24. Yaffe, M.B. et al. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91, 961-971 (1997).
25. Cardoso, C. et al. Refinement of a 400 kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome and other phenotypes secondary to deletions of 17p13.3. Am. J. Hum. Genet. 72, 918-930 (2003).
26. Bermingham, J. et al. Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev. 10, 1751-1762 (1996).
27. Fleck, M.W. et al. Hippocampal abnormalities and enhanced excitability in a murine model of human lissencephaly. J. Neurosci. 20, 2439-2450 (2000).
28. Huang, D., Patrick, G., Moffat, J., Tsai, L.H. & Andrews, B. Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase. Proc. Natl. Acad. Sci. USA 96, 14445-14450 (1999).
29. Floyd, S.R. et al. Amphiphysin 1 binds the cyclin-dependent kinase (cdk) regulatory subunit p35 and is phosphorylated by dck5 and cdk2. J. Biol. Chem. 276, 8104-8110 (2001).
30. Smith, D.S. et al. Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nat. Cell Biol. 2, 767-775 (2000).
31. Yan, X. et al. Human Nudel and NudE as regulators of cytoplasmic dynein in poleward protein transport along the mitotic spindle. Mol. Cell Biol. 23, 1239-1250 (2003).
32. Vincenz, C. & Dixit, V.M. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J. Biol. Chem. 271, 20029-20034 (1996).
33. Van Der Hoeven, P.C., Van Der Wal, J.C., Ruurs, P., Van Dijk, M.C. & Van Blitterswijk, J. 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation. Biochem. J. 345, 297-306 (2000).
34. Chang, H.C. & Rubin, G.M. 14-3-3 epsilon positively regulates Ras-mediated signaling in Drosophila. Genes Dev. 11, 1132-1139 (1997).
35. Broadie, K., Rushton, E., Skoulakis, E.M. & Davis, R.L. Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function. Neuron 19, 391-402 (1997).
36. Skoulakis, E.M. & Davis, R.L. Olfactory learning deficits in mutants for leonardo, a Drosophila gene encoding a 14-3-3 protein. Neuron 17, 931-944 (1996).
37. Faulkner, N.E. et al. A role for the lissencephaly gene LIS1 in mitosis and cytoplasmic dynein function. Nat. Cell Biol. 2, 784-791 (2000).
38. Liu, Z., Steward, R. & Luo, L. Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nat. Cell Biol. 2, 776-783 (2000).
39. Feng, Y. et al. Interactions between LIS1 and mNudE, a central component of the centrosome, are required for CNS lamination. Neuron 28, 665-679 (2000).
40. Veeranna et al. Neuronal cyclin-dependent kinase-5 phosphorylation sites in neuro-filament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 64, 2681-2690 (1995).
41. Sontag, E. et al. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17, 1201-1207 (1996).
42. Price, N.E., Wadzinski, B. & Mumby, M.C. An anchoring factor targets protein phosphatase 2A to brain microtubules. Brain Res. Mol. Brain Res. 73, 68-77 (1999).
43. Sontag, E. et al. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J. Biol. Chem. 274, 25490-25498 (1999).
44. Lin, F.C. & Arndt, K.T. The role of Saccharomyces cerevisiaetype 2A phosphatase in the actin cytoskeleton and entry into mitosis. EMBO J. 14, 2745-2759 (1995).
45. Gotz, J., Probst, A., Ehler, E., Hemmings, B. & Kues, W. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Cα. Proc. Natl. Acad. Sci. USA 95, 12370-12375 (1998).
46. Feller, S. et al. Physiological signals and oncogenesis mediated through Crk family adapter proteins. J. Cell Physiol. 177, 535-552 (1998).
47. Tsuda, M., Tanaka, S., Sawa, H., Hanafusa, H. & Nagashima, K. Signaling adaptor protein v-Crk activates rho and regulates cell motility in 3Y1 rat fibroblast cell line. Cell. Growth Differ. 13, 131-139 (2002).
48. Weinstein, D.E., Dobrenis, K. & Birge, R.B. Targeted expression of an oncogenic adaptor protein v-Crk potentiates axonal growth in dorsal root ganglia and motor neurons in vivo. Brain Res. Dev. Brain Res. 116, 29-39 (1999).
49. Hirotsune, S. etal. Genomic organization of the murine Miller-Dieker/lissencephaly region: conservation of linkage with the human region. Genome Res. 7, 625-634 (1997).
50. Sontag, E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell. Signal. 13, 7-16 (2001).